Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome.

The Journal of Gene Medicine
Linh PhamStephen J Russell

Abstract

Expression cassettes can be inserted at several positions into recombinant adenoviral genomes but the implications of this choice for transgene expression level have not been determined. Knowledge of the relative expression levels of transgenes inserted at different sites in the adenoviral genome is of particular significance for transgene expression monitoring approaches that rely on the concordant expression of a marker transgene inserted elsewhere in the viral genome. Three expression cassettes, each comprising a cytomegalovirus promoter driving one of three marker peptides [serum carcinoembryonic antigen (sCEA), beta subunit of human chorionic gonadotropin (betahCG) or human sodium iodide symporter (hNIS)], were inserted into E1, E3 or E4 cloning sites in a recombinant adenoviral vector backbone. High titer stocks of bicistronic adenoviral vectors coding for combinations of marker peptides were prepared. A panel of human cells of various lineages was infected with the vectors and expression ratios of the transgene-encoded proteins were analysed. Serum levels of the soluble proteins and hepatic uptake of radioactive iodine were also compared in vivo in nude rats after intravenous vector infusion. High concordance of expressi...Continue Reading

References

Jun 1, 1994·Japanese Journal of Medical Science & Biology·Y KanegaeI Saito
Jul 1, 1997·Nature Medicine·C Nyberg-HoffmanE Aguilar-Cordova
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·T VandenDriesscheM K Chuah
Sep 3, 1999·Nuclear Medicine and Biology·S S GambhirM E Phelps
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·S S GambhirH R Herschman
Dec 22, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·P W Zoltick, J M Wilson
May 2, 2002·Nature Medicine·Kah-Whye PengStephen J Russell
Mar 22, 2003·Blood·David DingliStephen J Russell
Jan 22, 2004·Seminars in Nuclear Medicine·Ekaterina Dadachova, Nancy Carrasco
Jul 10, 2004·Thyroid : Official Journal of the American Thyroid Association·Christine Spitzweg, John C Morris
Aug 28, 2004·Critical Reviews in Oncology/hematology·Harvey R Herschman
Oct 30, 2004·The Journal of Gene Medicine·Gunhild M MaelandsmoRobin J Parks
Nov 4, 2004·Biochemical and Biophysical Research Communications·David DingliJohn C Morris
Dec 6, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·David DingliVal J Lowe
Mar 23, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kosei HasegawaKah-Whye Peng
Oct 21, 2006·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Stephanie K CarlsonStephen J Russell
Apr 3, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Do Won HwangDong Soo Lee
Oct 9, 2007·Nuclear Medicine and Biology·Inna SerganovaRonald Blasberg
Sep 4, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sunetra RaySanjiv S Gambhir

❮ Previous
Next ❯

Citations

Mar 18, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Chunsheng LiuKah-Whye Peng
Jan 28, 2010·Virology Journal·Jing LiQiana L Matthews
Sep 13, 2013·Journal of Virology·Gurdeep SinghJames Chodosh
Oct 13, 2015·Expert Opinion on Biological Therapy·Amber Miller, Stephen J Russell
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Haibo WangShengfang Ge
Sep 17, 2011·Biotechnology Advances·Bakhos A Tannous, Jian Teng

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.